Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Inflammation 2Stomach Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Gynecological Laparoscopic Surgery 1Esophageal Neoplasms 1Emergence Delirium 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Exercise 5Vitamin D 2Tea 2Sufentanil 2Spironolactone 2Probiotics 2Oxycodone 2Omeprazole 2Morphine 2Metformin 2Etanercept 2Colchicine 2Ascorbic Acid 2ziprasidone 1soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1falcarinol 1falcarindiol 1epigallocatechin gallate 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Sulindac 1Sodium Salicylate 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Inflammation × Sufentanil × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed
26 enrolled
Genitourinary

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡